Spatial Concept
How the world’s biggest pharma and biotech companies paid their typical worker in 2023
2023, Midline (qualifier value), Gilead, Wages, Average, Highest
Compensation Trends in the Pharmaceutical and Biotech Industry: 2023 Insights
pharmaceutical industry, biotech companies, median salary, employee pay, compensation trends, 2023
Novo Nordisk Acquires 2seventy’s Gene Editing Technology and Haemophilia Candidate for $40 Million
Novo Nordisk, 2seventy, gene editing, haemophilia, MegaTAL, in vivo gene editing technology
Exsilio Emerges from Stealth with $82 Million to Revolutionize Gene Therapy
Exsilio Therapeutics, Gene Therapy, Novel Approach, mRNA, Lipid Nanoparticle Delivery, Biotech Company, Genetic Medicine
Navigating the Complexities of Adding Rare Disease Products to Your Company’s Portfolio
Rare disease products, biopharmaceutical development, commercialization, market access, patient identification, payer contract strategy, value-based contracting, regulatory incentives, emerging technology.
Emergent Biosolutions Sells Baltimore Facility for $30 Million
Emergent Biosolutions, Baltimore facility, sale, Bora, $30 million
Elion nets $81M to fund development of antifungal with lower toxicity risks
Antifungal Agents, Lower – spatial qualifier, Toxicity aspects, Risk, Elion
Western In-Licensing Deals with Chinese Companies: Focus on Disease Areas and Drug Types
, In-licensing deals, Chinese pharmaceutical companies, Western pharmaceutical companies, Disease areas, Drug types, Cross-border partnerships, Biopharma, Licensing trends,
RYBREVANT: A Breakthrough in Lung Cancer Treatment
RYBREVANT, lung cancer, EGFR mutations, subcutaneous administration, intravenous administration, infusion-related reactions, survival rate, non-small cell lung cancer (NSCLC)
Structure Therapeutics’ Oral GLP-1 Achieves Comparable Weight Loss to Lilly’s Candidate
Structure Therapeutics, GLP-1, Obesity, Weight Loss, Lilly, Oral Candidate